W

Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871

Watchlist Manager
Wuhan Hvsen Biotechnology Co Ltd
SZSE:300871
Watchlist
Price: 9.17 CNY -3.27% Market Closed
Market Cap: 1.5B CNY
Have any thoughts about
Wuhan Hvsen Biotechnology Co Ltd?
Write Note

Wuhan Hvsen Biotechnology Co Ltd
Investor Relations

HVSEN Biotechnology Co., Ltd. engages in the research and development, production, and sale of veterinary drugs. The company is headquartered in Wuhan, Hubei and currently employs 828 full-time employees. The company went IPO on 2020-08-24. The Company’s main products include veterinary active pharmaceutical ingredients, veterinary chemical preparations, veterinary traditional Chinese medicine preparations, feed and additives and environmental improvers, such as tyvanicin tartrate, florfenicol powder, banqing granules and piglet composites pre-mixed feed, etc. The firm mainly conducts its businesses in the China market.

Show more
Loading
300871
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Earnings Calls

No Earnings Calls Available

Management

Mr. Kaijie Yang
Deputy GM & CFO
No Bio Available
Mr. Zexiang Liu
Director & Assistant to the GM
No Bio Available
Mr. Qingfeng Wang
Board Secretary
No Bio Available
Mr. Jie Han
Deputy General Manager
No Bio Available
Ms. Hongxia Li
Director of Warehousing & Logistics Data and Supervisor
No Bio Available
Ms. Jian Zhou
Chairman of the Supervisory Board & Assistant to the GM
No Bio Available
Mr. Wenge Ding
Product & Technical Service Director and Supervisor
No Bio Available

Contacts

Address
HUBEI
Wuhan
No. 52 (the Intersection of National Highway 107 and Yousha Road), Yousha Road, Xingou Sub-district Office, Dongxihu District
Contacts
+862783235499
www.whhsyy.com